QOL Medical LLC
Ann C. Beyer is an accomplished professional in the pharmaceutical and medical sales industry, currently serving as an Executive Rare Disease Specialist at QOL Medical LLC since August 2014. Prior experience includes roles as a Senior Rare Disease Specialist and Sales Representative at ICM Distributing Company, where Ann managed sales for college bookstores and independent pharmacies across three states. Additionally, Ann operated as a Medical Database Consultant, leveraging extensive medical knowledge for database organization and cleanup. A significant tenure at Glaxo Smith Kline from 1987 to 2010 included the position of Senior Executive Sales Representative, where Ann promoted a wide range of medical products and led training programs. Ann holds a Bachelor of Science degree in Health Education from the State University of New York at Plattsburgh and attended Park School of Buffalo.
This person is not in any offices
QOL Medical LLC
OL Medical is a specialty biopharmaceutical company dedicated to improving the quality of life for patients with rare diseases, for their families, and for the physicians and caregivers who support them.QOL Medical is a patient-centric company founded in 2003 to focus on the acquisition and commercialization of orphan products in underservedmarkets. QOL Medical ensures an expanded clinical awareness and patient access for improved quality of life in the treatment of rare and orphan diseases. The Company currently markets two FDA-approved products: Sucraid® (sacrosidase) Oral Solution and Ethamolin® (Ethanolamine Oleate) Injection, 5%.QOL Medical, in its commitment to assuring safe and effective products for our customers, uses validated procedures through audited and approved vendors for manufacturing, testing, and distribution. Additionally, QOL Medical has procedures for product monitoring, customer complaints, investigations into nonconformities, and change control.